Disease areas
Our solutions can be applied to multiple disease areas. We currently focus on oncology, infection disease and neurology, but we are continuously expanding our portfolio. 
Medip Analytics - Clinical cost-effectiveness analyses pipeline 2024
The latest developments in our clinical cost-effectiveness analyses pipeline
Medip Analytics - Clinical cost-effectiveness analyses pipeline 2024Our applications for prostate and bladder cancer are now live and actively deployed, and we are currently developing applications for melanoma and lung cancer. Additionally, breast cancer is on our development roadmap of 2024. If you would like to learn more about our developments or have inquiries about a specific disease area not included on the roadmap, please feel free to contact us or directly schedule a meeting us.
Diagnostics encompass a range of technologies and tools designed to detect and monitor diseases with precision.
Prognostics involve the use of advanced technologies and algorithms to predict the likely course and outcome of diseases.
Companion diagnostics are specialized tests that identify patients most likely to benefit from specific treatments, ensuring personalized and effective therapy.
Ready to Unlock you product's potential?
Schedule a demo to see how Health Economic Software can improve the market uptake of your products.
